+

WO1990009092A3 - Nouveaux inducteurs puissants de differenciation terminale et procede d'utilisation de tels inducteurs - Google Patents

Nouveaux inducteurs puissants de differenciation terminale et procede d'utilisation de tels inducteurs Download PDF

Info

Publication number
WO1990009092A3
WO1990009092A3 PCT/US1989/005203 US8905203W WO9009092A3 WO 1990009092 A3 WO1990009092 A3 WO 1990009092A3 US 8905203 W US8905203 W US 8905203W WO 9009092 A3 WO9009092 A3 WO 9009092A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
amount
patient
terminal differentiation
proliferation
Prior art date
Application number
PCT/US1989/005203
Other languages
English (en)
Other versions
WO1990009092A2 (fr
Inventor
Paul A Marks
Richard A Rifkind
Ronald Breslow
Original Assignee
Univ Columbia
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/374,343 external-priority patent/US5055608A/en
Application filed by Univ Columbia, Sloan Kettering Inst Cancer filed Critical Univ Columbia
Priority to AU59271/90A priority Critical patent/AU5927190A/en
Priority to US07/522,558 priority patent/US5175191A/en
Priority to PCT/US1990/002690 priority patent/WO1991000257A1/fr
Publication of WO1990009092A2 publication Critical patent/WO1990009092A2/fr
Publication of WO1990009092A3 publication Critical patent/WO1990009092A3/fr
Priority to PCT/US1990/006649 priority patent/WO1991008191A1/fr
Priority to JP03501924A priority patent/JP3083842B2/ja
Priority to EP91901442A priority patent/EP0594577B1/fr
Priority to CA002068224A priority patent/CA2068224C/fr
Priority to ES91901442T priority patent/ES2128314T3/es
Priority to AT91901442T priority patent/ATE175185T1/de
Priority to AU69726/91A priority patent/AU643248B2/en
Priority to DE69032871T priority patent/DE69032871T2/de
Priority to US08/424,556 priority patent/US5608108A/en
Priority to US08/476,624 priority patent/US5840960A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention se rapporte à une classe de composés ayant au moins deux composants non polaires reliés par un groupe polaire et comportant des groupes polaires sur les terminaisons du composé. La présente invention se rapporte également à un procédé permettant d'induire sélectivement la différenciation des terminaisons des cellules néoplastiques et, par conséquent, d'inhiber la prolifération de telles cellules. Ledit procédé consiste à mettre en contact les cellules dans des conditions appropriées avec une quantité du composé suffisante pour induire sélectivement la différenciation terminale. La présente invention se rapporte en outre à un procédé permettant de traiter un patient ayant une tumeur qui se caractérise par la prolifération de cellules néoplastiques. Ledit procédé consiste à administrer au patient une quantité du composé suffisante pour induire sélectivement la différenciation terminale de ces cellules néoplastiques afin d'inhiber leur prolifération et de supprimer l'oncogénicité. La présente invention se rapporte enfin à une préparation pharmaceutique contenant un excipient pharmaceutiquement acceptable et le composé en une quantité efficace inférieure à une quantité qui entraînerait une toxicité pour le patient.
PCT/US1989/005203 1988-11-14 1989-11-14 Nouveaux inducteurs puissants de differenciation terminale et procede d'utilisation de tels inducteurs WO1990009092A2 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
AU59271/90A AU5927190A (en) 1989-06-30 1990-05-14 Novel potent inducers of terminal differentiation and methods of use thereof
US07/522,558 US5175191A (en) 1988-11-14 1990-05-14 Potent inducers of terminal differentiation and methods of use thereof
PCT/US1990/002690 WO1991000257A1 (fr) 1989-06-30 1990-05-14 Nouveaux inducteurs puissants de differenciation de terminaisons et leur mode d'emploi
DE69032871T DE69032871T2 (de) 1989-11-14 1990-11-14 Neue potente induktoren terminaler differenzierung und verfahren zu ihrer verwendung
AU69726/91A AU643248B2 (en) 1989-11-14 1990-11-14 Novel potent inducers of terminal differentiation and method of use thereof
AT91901442T ATE175185T1 (de) 1989-11-14 1990-11-14 Neue potente induktoren terminaler differenzierung und verfahren zu ihrer verwendung
JP03501924A JP3083842B2 (ja) 1989-11-14 1990-11-14 新規かつ強力な最終分化誘発剤及びその使用方法
PCT/US1990/006649 WO1991008191A1 (fr) 1989-11-14 1990-11-14 Nouveaux inducteurs puissants de differenciation de terminaisons et leur mode d'emploi
EP91901442A EP0594577B1 (fr) 1989-11-14 1990-11-14 Nouveaux inducteurs puissants de differenciation de terminaisons et leur mode d'emploi
CA002068224A CA2068224C (fr) 1989-11-14 1990-11-14 Nouveaux inducteurs efficaces de la phase terminale de la differenciation et methode d'utilisation
ES91901442T ES2128314T3 (es) 1989-11-14 1990-11-14 Nuevos inductores potentes de diferenciacion terminal y metodo de utilizacion de los mismos.
US08/424,556 US5608108A (en) 1988-11-14 1995-04-17 Potent inducers of terminal differentiation and method of use thereof
US08/476,624 US5840960A (en) 1988-11-14 1995-06-07 Potent inducers of terminal differentiation and method of use thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27096388A 1988-11-14 1988-11-14
US270,963 1988-11-14
US374,343 1989-06-30
US07/374,343 US5055608A (en) 1988-11-14 1989-06-30 Novel potent inducers of thermal differentiation and method of use thereof

Publications (2)

Publication Number Publication Date
WO1990009092A2 WO1990009092A2 (fr) 1990-08-23
WO1990009092A3 true WO1990009092A3 (fr) 1990-10-04

Family

ID=26954600

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1989/005203 WO1990009092A2 (fr) 1988-11-14 1989-11-14 Nouveaux inducteurs puissants de differenciation terminale et procede d'utilisation de tels inducteurs

Country Status (4)

Country Link
JP (1) JPH04500359A (fr)
AU (1) AU4835090A (fr)
CA (1) CA2002853A1 (fr)
WO (1) WO1990009092A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2128314T3 (es) * 1989-11-14 1999-05-16 Sloan Kettering Inst Cancer Nuevos inductores potentes de diferenciacion terminal y metodo de utilizacion de los mismos.
WO2003032921A2 (fr) 2001-10-16 2003-04-24 Sloan-Kettering Institute For Cancer Research Traitement des maladies neurodegeneratives et du cancer du cerveau

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614815A (en) * 1979-09-10 1986-09-30 Anic S.P.A. Process for producing diesterdiamides
US4882346A (en) * 1987-06-16 1989-11-21 The United States Of America As Reprsented By The Department Of Health And Human Services Chemical differentiating agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614815A (en) * 1979-09-10 1986-09-30 Anic S.P.A. Process for producing diesterdiamides
US4882346A (en) * 1987-06-16 1989-11-21 The United States Of America As Reprsented By The Department Of Health And Human Services Chemical differentiating agents

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PROC. NATL. ACAD. SCI. U.S.A., Vol. 72, March 1975, TANAKA et al., "Induction of Erythroid Differentiation in Murine Virus Infected Erythroleukemia Cells by Highly Polar Compounds", pages 1003-1006. *
THE JOURNAL OF BIOLOGICAL CHEMISTRY, Vol. 253, No. 12, June 1978, REUBEN et al., "Inducers of Erythroleukemic Differentiation", pages 4214-4218. *

Also Published As

Publication number Publication date
WO1990009092A2 (fr) 1990-08-23
AU4835090A (en) 1990-09-05
JPH04500359A (ja) 1992-01-23
CA2002853A1 (fr) 1990-05-14

Similar Documents

Publication Publication Date Title
ZA867387B (en) Pharmaceutical and dietary composition
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
AU2647495A (en) Novel potent inducers of terminal differentiation and methods of use thereof
EP0251717A3 (fr) Protéine chimiquement modifiée, activant les ílots
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
CA2068224A1 (fr) Nouveaux inducteurs efficaces de la phase terminale de la differenciation et methode d'utilisation
DE3562920D1 (en) Process for the preparation of polyurethanes, polyurethanes having aromatic amino terminal groups and their use
MY100900A (en) Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
UA27055C2 (uk) Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
IL67940A (en) 2,3-di(phenyl or pyridyl)-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
HUT62585A (en) Process for producing 6-amino-octahydro-indolizinetriole derivatives and phqrmaceutical compositions comprising same as active ingredient
CA2135709A1 (fr) Derives de melatonine servant au traitement des troubles du sommeil
WO1990009092A3 (fr) Nouveaux inducteurs puissants de differenciation terminale et procede d'utilisation de tels inducteurs
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
EP0576915A3 (en) Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
IE831030L (en) Benzopyrans and benzothiopyrans
ZA843489B (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives,processes for their preparation and their use in the combating of diseases of the central nervous system
EP0226842A3 (fr) 1,4-Naphtalènediones substitués, procédés pour leur préparation et compositions pharmaceutiques les contenant
ZA83252B (en) 3-alken (in)yl-mercapto (amino)-4-amino-6-tert.-butyl-1, 2, 4-triazin-5-ones, processes for their preparation, and their use as herbicides
IL89496A0 (en) Eglin mutants,their preparation and pharmaceutical compositions containing them
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
NZ240781A (en) Bis pilocarpine ester derivatives and medicaments for glaucoma treatment.
GR3018716T3 (en) 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU DK FI HU JP KP NO US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU DK FI HU JP KP NO US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载